Publication | Closed Access

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

InflammationAnti-inflammatoryMedicineImmune RegulationTumor ImmunityCancer Cell BiologyImmunologyImmune SurveillanceNonsteroidal Anti-inflammatory AgentsAnti-cancer AgentTumor Cell ProliferationNf-κb ActivationOncologyRadiation OncologyCancer ResearchTumor Biology